BCH: 2Q20 Earnings Should Be the Bottom Quarter
Yesterday analyst meeting came out with a neutral tone. We expect 2Q20 earnings to be the bottom quarter, given full quarter impact from COVID-19...
317 Views
CHG: Impeded by Covid-19 in 1H20 but Will Recover in 2H20
We maintain HOLD rating on CHG with a 2020E target price at Bt2.65, derived from a discounted cash flow valuation (WACC of 6.0% and terminal growth...
114 Views
BCH: Positive Sentiment from New Rate Adjustment for SSO Patients
Yesterday's analyst meeting came out with a positive tone. We maintain our BUY rating with a target price of Bt21.0 based on DCF on the back of...
368 Views
CHG: Call It a Day
We downgrade our recommendation on CHG to HOLD, from BUY, with new 2020E target price at Bt2.65, derived from a discounted cash flow valuation...
371 Views
CHG: On the Recovery Path
We maintain our BUY rating on CHG with a 2019E target price of Bt2.53, derived from a discounted cash flow valuation (WACC of 6.2% and terminal...
413 Views